SEALSQ VP Enguent Jean-Pierre Exercises Options, Sells 15,000 Shares

What Happened
Enguent Jean‑Pierre, Vice President, R&DSS at SEALSQ Corp (LAES), exercised options on 2026-09-01 to acquire 15,000 shares at $0.01 per share (cash cost $150). The filing also shows a derivative disposition of 15,000 shares on 2026-09-01 (reported at $0.00). On 2026-09-03 he sold 15,000 shares in the open market at a weighted average price of $2.40 per share, generating approximately $36,030. The sale was executed pursuant to a pre-established Rule 10b5‑1 trading plan.

Key Details

• Transaction dates: Option exercise and derivative entry on 2026-09-01; open‑market sale on 2026-09-03. Form 4 filed 2026-09-03 (reporting period 2026-09-01).
• Exercise: 15,000 shares acquired at $0.01/share (total $150).
• Disposition (derivative): 15,000 shares reported disposed at $0.00 on 2026-09-01 (filing lists as a derivative transaction).
• Sale: 15,000 shares sold at weighted avg $2.40/share for ~$36,030; prices in the sale ranged from $2.38 to $2.4253 (report discloses weighted‑avg and offers to provide per‑trade details on request).
• Footnotes: Both the sale and the option exercise were effected pursuant to a Rule 10b5‑1 trading plan adopted Oct 13, 2025. The filer offers to provide breakdown of sales by price within the disclosed range.
• Shares owned after the transaction: Not specified in the filing.

Context

• This filing shows an option exercise followed by a sale under a 10b5‑1 plan. That pattern is commonly used to monetize option gains while complying with prearranged trading rules; the filing does not state motivations.
• The 10b5‑1 plan means the sale was preplanned and executed according to the plan’s terms, which can reduce the significance of the sale as a discretionary signal.